Results

Total Results: 900 records

Showing results for "author year description".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_research-protocol.pdf
    April 01, 2013 - Tumor (T) stages Stage Description T1 The tumor cannot be felt or seen using imaging techniques T1a … Lymph node (N) stages Stage Description NX Nearby lymph nodes were not assessed N0 The cancer has … publications reporting subgroups, other outcomes, longer followup) will be identified by examining author … meta-analyses are possible, meta-regression models will be used to analyze possible interactions with the year … OR (year ADJ old).ti,ab.) 10 Limit Limit 9 to English and humans and yr=“2007-Current” 11 Remove
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/off-label-use-research-priorities_research.pdf
    May 01, 2009 - ........................................................................................... 18 Author … P res c ribing Data For its large size (approximately 200,000 contact records per year), national scope … to year. … Report Number 12 18 Appendix The purpose of this appendix is to augment the detailed study description … of the TEP Further Description of Methods and Coding Further Description of Technical Expert Panel
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/improving-utility-evidence-synthesis-white-paper.pdf
    April 01, 2021 - Strategies for addressing insufficient evidence in evidence synthesis programs* Strategy Description … Example Example Description Reconsider eligible study designs In designing the original protocol … Example Example Description Summarize evidence on contextual factors (factors other than benefits … Example Example Description Incorporate health system data into a review Local health system data … Heart. 2010 Aug;96(16):1333; author reply doi: https://dx.doi.org/10.1136/hrt.2010.200758.
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief2-opioid-withdrawal.pdf
    April 01, 2021 - to the systematic reviews found that among patients prescribed long-term opioid therapy in the last year … Studies of treatments to support opioid tapering in patients with chronic pain Strategy Description … Patient-centered prescription opioid tapering in community outpatients with chronic pain: 2- to 3-year … This report is made available to the public under the terms of a licensing agreement between the author … See Appendix B for detailed description of the criteria.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-brief2-opioid-withdrawal.pdf
    April 01, 2021 - to the systematic reviews found that among patients prescribed long-term opioid therapy in the last year … Studies of treatments to support opioid tapering in patients with chronic pain Strategy Description … Patient-centered prescription opioid tapering in community outpatients with chronic pain: 2- to 3-year … This report is made available to the public under the terms of a licensing agreement between the author … See Appendix B for detailed description of the criteria.
  6. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/postpartum-care-one-year-protocol-amendment.pdf
    April 25, 2022 - Postpartum Care for Women Up to One Year After Pregnancy Evidence-based Practice Center … Systematic Review Protocol Project Title: Postpartum Care for Women Up to One Year After Pregnancy … 11.8).2 Approximately half (52%) of the deaths occurred in the postpartum period (defined as up to 1 year … after giving birth).2, 3 Additionally, up to 70,000 individuals per year in the U.S. experience severe … For KQ 1b: 3 months to 1 year after giving birth (except interpregnancy interval, unintended
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
    September 01, 2011 - the differentiation into Tiers 1-3 and MMD alone or mixed groups, I struggled to find a compelling description … Earlier this year, Janicak and colleagues published the results of a 6-month naturalistic follow-up … Peer Reviewer #8 General Nemeroff [et al., PNAS, 2003—and Michael Thase was a co-author] studied … "Two-year outcome of vagus nerve stimulation in treatment-resistant depression." … "Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes."
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-210-breastfeeding-disposition-comments.pdf
    January 01, 2020 - The table does not include any description of “time frame” as required by the PICOTS framework. … standard list to assess all potentially eligible studies, and do not go back in time to match the year … There is room in the first column if this could be explanded to Author, Year, Country, ROB. … TEP Reviewer 1 Discussion/ Conclusion Other comments Pg 113 Ln 16-18 The description of studies … The way it is written, the text sometimes conveys it was the author who did not analyze by subgroup
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline-disposition-170707pdf.pdf
    March 24, 2017 - It includes a reasonable background literature description, it provides definitions for relevant terminology … Did you follow this approach and if yes, revise this description to improve clarity. … We have revised some elements of the description of the ACTIVE trial. … We have revised our description of the booster assignment but it does not alter the bias conclusion … They do a good job with their description of how bias was rated.
  10. effectivehealthcare.ahrq.gov/sites/default/files/cognitive-decline-disposition-170707pdf.pdf
    March 24, 2017 - It includes a reasonable background literature description, it provides definitions for relevant terminology … Did you follow this approach and if yes, revise this description to improve clarity. … We have revised some elements of the description of the ACTIVE trial. … We have revised our description of the booster assignment but it does not alter the bias conclusion … They do a good job with their description of how bias was rated.
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections_disposition-comments.pdf
    March 01, 2012 - pre-existing conditions documented, are all identical to those reported in another study by the same author … We reworded the sample description to clarify that all subjects had recurrent CDI. … We reworded the sample description to clarify that all subjects had recurrent CDI Peer Reviewer #4 … PCP office in a flowchart method – IF patient presents with weight loss AND had surgery in the past yearDescription of studies evaluating risk factors for Clostridium difficile associated diarrhea (CDAD)
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-search_methods.pdf
    July 01, 2012 - MEDLINE EMCare http://www.elsevier.com/wps/find/bibliographicdataba sedescription.cws_home/708272/description … # description Nursing and allied health Global Health http://www.cabi.org/datapage.asp? … Stroke, 2008. 39(8):e139; author reply e140. [Comment on Stroke 2008;39(6):1911-9.] 23. … Conflicts of interest: The author has no affiliations or financial involvements that conflict with the … Corresponding author: Rose Relevo, M.L.I.S., M.S.
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/telehealth_disposition-comments.pdf
    June 30, 2016 - section on how we incorporated quality criteria for the systematic reviews into our inclusion and description … Tables can be copied and if they have a fuller description of what each contains via the title, the … TeleMental Health The number of veterans receiving care through telehealth is climbing by 22% each year … Riley, PhD, corresponding author Pamela Keberlein, RN, MSN, Gigi Sorenson, RN, MSN, Sailor Mohler … We revised the description of inclusion criteria to clarify that we did not restrict our inclusion to
  14. effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
    January 01, 2010 - These spreadsheets will allow each author to count key data points, such as study location, study type … evidence table will vary by key question, but the tables will contain some common elements, such as author … , year of publication, study location (e.g., country, city, state) and time period, population description … Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
    December 09, 2009 - These spreadsheets will allow each author to count key data points, such as study location, study type … evidence table will vary by key question, but the tables will contain some common elements, such as author … , year of publication, study location (e.g., country, city, state) and time period, population description … Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_disposition-comments.pdf
    October 01, 2010 - evidence to show that adverse events associated with RFA are relatively uncommon….based on the study description … Nonrandomized studies of AF ablation that measured QoL outcomes were reviewed earlier this year.(1) … • This study evaluated 105 patients followed for one year. … RFA was superior to medical treatments at maintaining sinus rhythm in patients with PAF over one year
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_disposition-comments.pdf
    August 12, 2016 - We have added a short description of FFQ and their deficiencies regarding n-3 FA to the introduction … Perhaps a brief description of the methodology to quantitate omega-3 levels for the included studies … Thank you Peer Reviewer #2 Introduction The brief description of the metabolic pathway of conversion … Peer Reviewer #2 Introduction The description of biomarkers used to assess n3 FA levels is appropriate … The sample size was too small (N<30) in each arm at 1 year followup.
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
    May 16, 2013 - Cycle 1 (1st assessment) In total, 4 CER-specific (e.g., lead author, clinical content experts, and … Based on the study description, we surmised that most of the adverse events either took place in a … . 319 (32%), p=0.005 Source: www.effectivehealthcare.ahrq.gov Published online: May 16, 2013 Author … 14/61 (23%), p=0.001 Source: www.effectivehealthcare.ahrq.gov Published online: May 16, 2013 Author … PV NA Complications Source: www.effectivehealthcare.ahrq.gov Published online: May 16, 2013 Author
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/predictors-trauma-care_research-protocol.pdf
    May 31, 2017 - <90 mmHg and respiratory rate less <10 or >29 breaths per minute (>20 in infants aged less than 1 year … studies used to support the trauma triage guidelines has increased 24-fold from approximately two per year … in the 2006 guidelines to about 48 per year in the 2011 guideline.10 Other developments, including … Management For studies that meet inclusion criteria, the following data will be abstracted: study design, year … risk of bias studies include clear descriptions of the population, setting, and measures; sufficient description
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-protocol-amendment.pdf
    March 22, 2023 - considered normal for their age (e.g., a study on how to manage a toddler’s temper tantrum or an 8- year-old … Criteria for grading the risk of bias of individual studies Rating Description and Criteria Low • Least … Description of the strength of evidence grades Strength of Evidence Description High We are very confident … stable or that the estimate of effect is close to the true effect. 11 Strength of Evidence Description

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: